unoprostone isopropyl   Click here for help

GtoPdb Ligand ID: 8282

Synonyms: Rescula® (proposed trade name) | UF 021 | UF-021
Approved drug
unoprostone isopropyl is an approved drug (FDA (2000))
Compound class: Synthetic organic
Comment: Note that the INN for this compound is for the carboxylic acid, whereas the compound used clinically is the isopropyl ester.
Unoprostone was originally developed as an intraocular pressure-reducing agent for use in glaucoma, however use for this indication has been discontinued. The focus is now on unoprostone's ability to treat retinal disease [3,5].
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: unoprostone isopropyl

2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 17
Topological polar surface area 83.83
Molecular weight 424.32
XLogP 5.39
No. Lipinski's rules broken 2
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCCCCCCC(=O)CCC1C(O)CC(C1CC=CCCCC(=O)OC(C)C)O
Isomeric SMILES CCCCCCCC(=O)CC[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)OC(C)C)O
InChI InChI=1S/C25H44O5/c1-4-5-6-7-10-13-20(26)16-17-22-21(23(27)18-24(22)28)14-11-8-9-12-15-25(29)30-19(2)3/h8,11,19,21-24,27-28H,4-7,9-10,12-18H2,1-3H3/b11-8-/t21-,22-,23+,24-/m1/s1
InChI Key XXUPXHKCPIKWLR-JHUOEJJVSA-N
No information available.
Summary of Clinical Use Click here for help
Both the EMA and FDA have granted unoprostone isopropyl orphan drug status for the treatment of the rare condition retinitis pigmentosa (RP) [7]. A Phase 2I clinical trial assessing unoprostone isopropyl as a treatment for RP is ongoing. A Phase 2 study in patients with dry age-related macular degeneration has been completed.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Unoprostone isopropyl is a topically applied prostaglandin analogue, with a docosanoid-like structure. Docosanoids are signaling molecules with neuroprotective and anti-inflammatory actions [1]. The reported affinity of unoprostone for prostaglandin receptors is very low [4], suggesting an alternative mechanism of action. The beneficial effects of unoprostone in RP appear to be mediated by activation of Ca2+-activated K+ (BK) channels [6], with an EC50 for activation of BK channels by unoprostone of approximately 0.6 nM in human cortical cells [2].